Purple Biotech Ltd. SEC filings PPBT
Purple Biotech Ltd. has 576 filings in SEC EDGAR's recent list, going back to Aug 18, 2014. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Aug 10, 2026 |
| 6-K | Current report (foreign issuer) | Aug 7, 2026 | Aug 7, 2026 |
| 6-K | Current report (foreign issuer) | Jul 29, 2026 | Jul 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 23, 2026 | Jun 23, 2026 |
| 6-K | Current report (foreign issuer) | Jun 11, 2026 | Jun 11, 2026 |
| F-3 | Shelf registration (foreign issuer) | May 20, 2026 | — |
| 6-K | Current report (foreign issuer) | May 15, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 27, 2026 | Apr 27, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 23, 2026 |
| 3 | Initial insider ownership | Apr 17, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 7, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 6, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 18, 2026 |
| 3/A | Filing | Mar 30, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 30, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 27, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 25, 2026 | Mar 25, 2026 |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Mar 18, 2026 |
| 20-F | Annual report (foreign issuer) | Mar 19, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 17, 2026 | Mar 17, 2026 |
| 6-K | Current report (foreign issuer) | Mar 13, 2026 | Mar 13, 2026 |
| 6-K | Current report (foreign issuer) | Feb 25, 2026 | Feb 25, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 7, 2026 | Jan 7, 2026 |
| 6-K | Current report (foreign issuer) | Dec 16, 2025 | Dec 16, 2025 |
| 6-K | Current report (foreign issuer) | Dec 11, 2025 | Dec 11, 2025 |
| 6-K | Current report (foreign issuer) | Nov 19, 2025 | Nov 19, 2025 |
| 6-K | Current report (foreign issuer) | Nov 14, 2025 | Nov 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 29, 2025 | Oct 29, 2025 |
| 6-K | Current report (foreign issuer) | Oct 28, 2025 | Oct 28, 2025 |
| 6-K | Current report (foreign issuer) | Oct 20, 2025 | Oct 20, 2025 |
| 6-K | Current report (foreign issuer) | Sep 19, 2025 | Sep 19, 2025 |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 16, 2025 | Sep 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 10, 2025 | Sep 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 9, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 9, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 5, 2025 |
| 424B4 | Prospectus | Sep 5, 2025 | — |
| EFFECT | Filing | Sep 4, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 4, 2025 | Sep 4, 2025 |
| 6-K | Current report (foreign issuer) | Sep 3, 2025 | Sep 3, 2025 |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Aug 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 6, 2025 | Aug 6, 2025 |
| 6-K | Current report (foreign issuer) | Jul 23, 2025 | Jul 23, 2025 |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 10, 2025 | Jul 10, 2025 |
| DRS | Filing | Jul 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 23, 2025 | Jun 23, 2025 |
| 6-K | Current report (foreign issuer) | Jun 17, 2025 | Jun 17, 2025 |
| 6-K | Current report (foreign issuer) | May 21, 2025 | May 21, 2025 |
| 6-K | Current report (foreign issuer) | May 12, 2025 | May 12, 2025 |
| 6-K | Current report (foreign issuer) | May 6, 2025 | May 6, 2025 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Apr 28, 2025 | Apr 28, 2025 |
| 6-K | Current report (foreign issuer) | Apr 22, 2025 | Apr 22, 2025 |
| 6-K | Current report (foreign issuer) | Apr 16, 2025 | Apr 16, 2025 |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 15, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2025 | Apr 1, 2025 |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Mar 28, 2025 |
| 6-K | Current report (foreign issuer) | Mar 18, 2025 | Mar 18, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 10, 2025 | Dec 31, 2024 |
| 6-K/A | Amendment no. 1 to form 6-k | Mar 10, 2025 | Mar 10, 2025 |
| 6-K | Current report (foreign issuer) | Mar 10, 2025 | Mar 10, 2025 |
| 6-K | Current report (foreign issuer) | Mar 5, 2025 | Mar 5, 2025 |
| 6-K | Current report (foreign issuer) | Feb 28, 2025 | Feb 28, 2025 |
| 6-K | Current report (foreign issuer) | Feb 18, 2025 | Feb 18, 2025 |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Current report (foreign issuer) | Jan 6, 2025 | Jan 6, 2025 |
| 424B5 | Prospectus supplement | Jan 6, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 6, 2024 | Dec 6, 2024 |
| 6-K | Current report (foreign issuer) | Dec 5, 2024 | Dec 5, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| 424B5 | Prospectus supplement | Dec 4, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 3, 2024 | Dec 3, 2024 |
| 6-K | Current report (foreign issuer) | Dec 2, 2024 | Dec 2, 2024 |
| 6-K | Current report (foreign issuer) | Nov 15, 2024 | Nov 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 4, 2024 | Nov 4, 2024 |
| 6-K | Current report (foreign issuer) | Oct 25, 2024 | Oct 25, 2024 |
| 6-K | Current report (foreign issuer) | Oct 10, 2024 | Oct 10, 2024 |
| 6-K | Current report (foreign issuer) | Oct 9, 2024 | Oct 9, 2024 |
| 6-K | Current report (foreign issuer) | Oct 2, 2024 | Oct 2, 2024 |
| 6-K | Current report (foreign issuer) | Sep 18, 2024 | Sep 18, 2024 |
| 6-K | Current report (foreign issuer) | Sep 11, 2024 | Sep 11, 2024 |
| 6-K | Current report (foreign issuer) | Aug 19, 2024 | Aug 19, 2024 |
| 6-K | Current report (foreign issuer) | Aug 16, 2024 | Aug 16, 2024 |
| 6-K | Current report (foreign issuer) | Aug 8, 2024 | Aug 8, 2024 |
| 6-K | Current report (foreign issuer) | Aug 5, 2024 | Aug 5, 2024 |
| 424B3 | Prospectus | Jul 31, 2024 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2024 | — |
| 6-K | Current report (foreign issuer) | Jul 25, 2024 | Jul 25, 2024 |
| F-1 | Registration statement (foreign issuer) | Jul 22, 2024 | — |
| 6-K | Current report (foreign issuer) | Jul 19, 2024 | Jul 19, 2024 |
| D | Filing | Jul 15, 2024 | — |
| 424B3 | Prospectus | Jul 2, 2024 | — |
| 6-K | Current report (foreign issuer) | Jul 2, 2024 | Jul 2, 2024 |
| 6-K | Current report (foreign issuer) | Jul 2, 2024 | Jul 2, 2024 |
| 6-K | Current report (foreign issuer) | Jul 1, 2024 | Jul 1, 2024 |
| 6-K | Current report (foreign issuer) | Jun 27, 2024 | Jun 27, 2024 |
| 6-K | Current report (foreign issuer) | Jun 26, 2024 | Jun 26, 2024 |
| 6-K | Current report (foreign issuer) | Jun 20, 2024 | Jun 20, 2024 |
| 6-K | Current report (foreign issuer) | Jun 4, 2024 | Jun 4, 2024 |
| 6-K | Current report (foreign issuer) | Jun 3, 2024 | Jun 3, 2024 |
| 6-K | Current report (foreign issuer) | May 21, 2024 | May 21, 2024 |
| 6-K | Current report (foreign issuer) | May 2, 2024 | May 2, 2024 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| EFFECT | Filing | Apr 2, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 28, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 28, 2024 | Mar 28, 2024 |
| 6-K | Current report (foreign issuer) | Mar 14, 2024 | Mar 14, 2024 |
| 6-K | Current report (foreign issuer) | Mar 6, 2024 | Mar 6, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 5, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 5, 2024 | Mar 5, 2024 |
| 6-K | Current report (foreign issuer) | Feb 27, 2024 | Feb 27, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Feb 13, 2024 | Feb 13, 2024 |
| 6-K | Current report (foreign issuer) | Feb 1, 2024 | Feb 1, 2024 |
| 6-K | Current report (foreign issuer) | Jan 26, 2024 | Jan 26, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 20, 2023 |
| 6-K | Current report (foreign issuer) | Dec 14, 2023 | Dec 14, 2023 |
| 6-K | Current report (foreign issuer) | Nov 21, 2023 | Nov 21, 2023 |
| 6-K | Current report (foreign issuer) | Nov 21, 2023 | Nov 21, 2023 |
| EFFECT | Filing | Nov 14, 2023 | — |
| 424B3 | Prospectus | Nov 14, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| F-1/A | Amendment no. 1 to form f-1 | Nov 13, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 2, 2023 | Nov 2, 2023 |
| D | Filing | Oct 31, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Oct 30, 2023 | — |
| 424B3 | Prospectus | Oct 19, 2023 | — |
| 6-K | Current report (foreign issuer) | Oct 19, 2023 | Oct 19, 2023 |
| 6-K | Current report (foreign issuer) | Oct 19, 2023 | Oct 19, 2023 |
| 424B5 | Prospectus supplement | Oct 19, 2023 | — |
| 6-K | Current report (foreign issuer) | Oct 17, 2023 | Oct 17, 2023 |
| 424B5 | Prospectus supplement | Oct 17, 2023 | — |
| 6-K | Current report (foreign issuer) | Oct 13, 2023 | Oct 13, 2023 |
| 6-K | Current report (foreign issuer) | Oct 6, 2023 | Oct 6, 2023 |
| 6-K | Current report (foreign issuer) | Oct 3, 2023 | Oct 3, 2023 |
| 6-K | Current report (foreign issuer) | Sep 21, 2023 | Sep 21, 2023 |
| 6-K | Current report (foreign issuer) | Sep 13, 2023 | Sep 13, 2023 |
| 6-K | Current report (foreign issuer) | Aug 22, 2023 | Aug 22, 2023 |
| 6-K | Current report (foreign issuer) | Jul 11, 2023 | Jul 11, 2023 |
| 6-K/A | Amendment no. 1 to form 6-k | Jun 20, 2023 | Jun 15, 2023 |
| 6-K | Current report (foreign issuer) | Jun 15, 2023 | Jun 15, 2023 |
| EFFECT | Filing | May 22, 2023 | — |
| 6-K | Current report (foreign issuer) | May 22, 2023 | May 22, 2023 |
| CORRESP | Letter to the SEC | May 18, 2023 | — |
| F-3/A | Amendment no. 1 to form f-3 | May 17, 2023 | — |
| 6-K | Current report (foreign issuer) | May 16, 2023 | May 16, 2023 |
| 6-K | Current report (foreign issuer) | May 1, 2023 | May 1, 2023 |
| 6-K | Current report (foreign issuer) | Apr 25, 2023 | Apr 25, 2023 |
| 6-K | Current report (foreign issuer) | Apr 19, 2023 | Apr 19, 2023 |
| EFFECT | Filing | Apr 5, 2023 | — |
| 424B3 | Prospectus | Apr 5, 2023 | — |
| CORRESP | Letter to the SEC | Apr 3, 2023 | — |
| 424B3 | Prospectus | Apr 3, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 24, 2023 | Mar 24, 2023 |
| F-3 | Shelf registration (foreign issuer) | Mar 23, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 16, 2023 | Mar 16, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 3, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Feb 14, 2023 | Feb 14, 2023 |
| 6-K | Current report (foreign issuer) | Feb 8, 2023 | Feb 8, 2023 |
| 6-K | Current report (foreign issuer) | Feb 3, 2023 | Feb 3, 2023 |
| 6-K | Current report (foreign issuer) | Feb 2, 2023 | Feb 2, 2023 |
| 6-K | Current report (foreign issuer) | Jan 6, 2023 | Jan 6, 2023 |
| 6-K | Current report (foreign issuer) | Jan 3, 2023 | Jan 3, 2023 |
| UPLOAD | Letter from the SEC | Dec 12, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 8, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 15, 2022 | Nov 15, 2022 |
| 6-K | Current report (foreign issuer) | Nov 9, 2022 | Nov 9, 2022 |
| 6-K | Current report (foreign issuer) | Nov 8, 2022 | Nov 8, 2022 |
| 6-K | Current report (foreign issuer) | Nov 2, 2022 | Nov 2, 2022 |
| 6-K | Current report (foreign issuer) | Aug 25, 2022 | Aug 25, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Aug 4, 2022 |
| 6-K | Current report (foreign issuer) | Jul 18, 2022 | Jul 18, 2022 |
| 6-K | Current report (foreign issuer) | Jul 14, 2022 | Jul 14, 2022 |
| 6-K | Current report (foreign issuer) | Jun 6, 2022 | Jun 6, 2022 |
| 6-K | Current report (foreign issuer) | May 27, 2022 | May 27, 2022 |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| 6-K | Current report (foreign issuer) | May 12, 2022 | May 12, 2022 |
| 6-K | Current report (foreign issuer) | May 2, 2022 | May 2, 2022 |
| 6-K/A | Amendment no. 1 to form 6-k | Apr 11, 2022 | Apr 11, 2022 |
| 6-K | Current report (foreign issuer) | Apr 11, 2022 | Apr 11, 2022 |
| S-8 | Employee stock plan registration | Apr 4, 2022 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPBT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Rehovot, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1614744
- Former names
- Kitov Pharma Ltd. (until Dec 10, 2020); Kitov Pharmaceuticals Holdings Ltd. (until Dec 21, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.